Terms ending in 2038
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,745,681 | Penicillin-G Acylases In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 11,141,410 | Oxazolidinones as Taro Inhibitors In force · High confidence | Merck Sharp & Dohme Corp. | In force | High confidence | |
| US 11,326,211 | Blood-Based Biomarkers of Tumor Sensitivity to PD-1 Antagonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,786,488 | Substituted Quinolizine Derivatives Useful as HIV Integrase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,261,711 | Proof of Non-Tampering for Stored Data In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,197,921 | Methods for Making Polysaccharide-Protein Conjugates In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,883,502 | Methods for Production of Capsular Polysaccharide Protein Conjugates from Streptococcus Pneumoniae Serotype 19F In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,141,403 | Benzimidazoles and Indoles as Taro Inhibitors In force · High confidence | Merck Sharp & Dohme Corp. | In force | High confidence | |
| US 10,947,222 | Indole Derivatives Useful as Inhibitors of Diacylglyceride O-Acyltransferase 2 In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,096,930 | Novel Substituted Imidazopyridine Compounds as Inhibitors of Indoleamine 2,3-Dioxygenase And/Or TRYPTOPHAN-2,3-Dioxygenase In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 106 more term ends in 2038 · Pro | |||||
10 of 116 patents shown. Soonest term end first, then patent number.
Pro members see all 116.
109 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.